Antimicrobial susceptibility
Phenotypic AST of the isolated uropathogens showed resistance against 0 to 6 drug 2 4 1 classes per isolate, with resistance against an average of 3 drug classes per isolate, cumulating to 2 4 2 38 cases of AMR against a drug class for all 15 uropathogens together( Nine of 11 urine samples from the UTI group were available for metagenomic resistome 2 4 6 analysis. These 9 samples contained 13 of the 15 cultured uropathogens, comprising 32 cases of 2 4 7 resistance against an antimicrobial drug class, as per phenotypic AST. Metagenomic resistome 2 4 8 analysis and phenotypic AST were concordant in 20 out of 32 cases (Table 2) . Five isolates (2 E. cloacae, 1 K. pneumoniae, 1 M. morganii and 1 P. mirabilis) derived 2 5 0 from individual urine samples showed a nitrofurantoin resistance phenotype, but a nitrofurantoin 2 5 1 resistance conferring gene was not detected, neither by metagenomic resistome nor by WGS 2 5 2 1 3 analysis. Metagenomics did not detect a matching AMR gene to explain seven additional 2 5 3 resistance phenotypes in five samples (Table 2) whilst AMR genes corresponding to these 2 5 4 phenotypes were detected in the WGS assembly of the isolates. In four samples, different AMR genes were identified by metagenomics and WGS of the 2 5 6 corresponding isolate, although both could explain the phenotype (Table 2 ). In 2 of these samples 2 5 7
(bla SHV and bla TEM genes detected by WGS in sample 19 and bla DHA genes in sample 45), 2 5 8 coverage of the metagenomic datasets was too low to distinguish the highly homologous gene 2 5 9 variants (5-10 SNP differences between identified genes) (Supplementary data, Figure 4 ). The 2 6 0 third, a bla ACT-28 gene detected by WGS in sample 7 was absent in the CosmosID database and 2 6 1 was instead identified as the bla ACT-9 gene (a close variant with 5 SNPs difference) in the Metagenomics outperformed WGS in three cases. In sample 28, containing E. coli 2 6 6 phenotypically resistant to 3 rd generation cephalosporins, metagenomics identified an ampC gene, 2 6 7 whilst WGS detected bla , which encodes resistance against penicillins, but not 3 rd 2 6 8 generation cephalosporins. In two instances a resistance encoding genotype was identified by 2 6 9 metagenomics but an equivalent coding gene was not detected in the corresponding WGS 2 7 0 analysis. Both genotypes matched to a resistant phenotype: oqxA and oqxB coding for norfloxacin 2 7 1 resistance in sample 45 and ampC for amoxicillin resistance in sample 23. The time from urine arrival at the laboratory to obtaining results by culture was This study demonstrates the potential of metagenomics for rapid detection of clinically 2 9 1 relevant levels of uropathogens, thus distinguishing UTI from non-UTI urine samples. Whilst several reports were previously published on the microbial community clinical samples has only been reported once to the best of our knowledge(7). However, that 2 9 5 1 5 study did not include the semi-quantitative analysis required to establish a diagnosis of UTI(2, 3, 2 9 6 26). If metagenomics is to replace culture, a semi-quantitative analysis of clinically relevant 2 9 7 bacteria present within the urine microbial community is critical to obtain a diagnostic test result, 2 9 8 as has been done in this study. Whilst all samples of the UTI group yielded >203.5 ng of DNA, 12 of 21 samples above 3 0 0 this threshold were non-UTI urine samples, reflective of the fact that the procedure of urine 3 0 1 sample collection is highly prone to bacterial contamination and that urine itself is not sterile(27). However, for none of the UTI samples was a low amount of DNA (<200 ng) associated with DNA was extracted which ranged between 2 and 20 ml (data not shown). This observation The total amount of time needed to detect and identify uropathogens and AMR genes in 3 1 0 the UTI samples was significantly less (31h vs. 48-72hs) for metagenomics than for standard 3 1 1 culture whilst metagenomics provided greater detail. Automated library preparation will further 3 1 2 reduce processing time of UTI samples by several hours. Metagenomic costs were €116 vs. €10 for culture per sample. Although metagenomic sequencing is more expensive at the present time, be ruled out in a low yield DNA sample within 4.5 hours and costs would be reduced to the cost 3 1 7 of DNA extraction -approximately €5 -making metagenomics highly competitive. Overlapping values for the UTI and non-UTI samples were observed for both DNA 3 1 9 quantity and relative abundance of uropathogens, indicating these parameters are unsuitable for 3 2 0 identifying urine samples from patients with UTI. However, the DI discriminated UTI and non-3 2 1 UTI samples extremely well. The single outlier was a sample containing Aerococcus urinae in 3 2 2 high relative abundance and high DNA yield, that had been reported to be culture negative, even because of its morphological similarity to coagulase negative staphylococci(29), leading to false 3 2 5 negative culture results. Metagenomic analysis was successfully employed to identify uropathogens in all but two 3 2 7 of the culture positive urine samples (Table 1 ). In the initial analysis Morganella morganii in the apparent lack of S. aureus DNA, since an extensive pre-lysis protocol was used, although this 3 3 3 cannot be ruled out(30). Alternatively, contamination of the agar plates may have occurred. CosmosID metagenomic bioinformatics system identified AMR encoding genes that were 3 3 5 confirmed to be present by pure isolate WGS analysis. However for a selected number of cases, 3 3 6 metagenomic and WGS analyses identified a highly similar, but non-identical AMR gene. An 3 3 7 explanation for this discrepancy can be the different databases used in the metagenomic and 3 3 8 WGS analysis. For WGS, it has been shown that different bioinformatic AMR identification tools produce different results and that databases are often incomplete(31). In addition, low coverage differences between metagenomics and WGS. Interestingly, even though metagenomic and WGS 3 4 2 methods identified different gene variants in those few instances, the variants were predicted to 3 4 3 encode the same phenotype. However, accurate phenotype prediction on the basis of genomic In conclusion, we provided a proof of concept of semi-quantitative metagenomic and negative predictive value of this metagenomics analysis approach applied to urine samples 3 5 5 using culture as the reference test. UTI. The median DI for the UTI group was 512.0 (IQR 382.8) versus 0.11 (IQR 5.4) for the 3 8 0 non-UTI group, which was a significant difference (p < 0.00001, Mann Whitney-U test). The red uropathogen in this study. Culture showed no growth. 
